Search results for " biopharmaceuticals" in Articles / App Notes
								 					Article
				
				Selecting the Right Viral Clearance Technology
								“While traditionally viral clearance has been achieved during the downstream processing of biopharmaceuticals, increasingly there is a focus on ensuring that raw materials are free of adventitious age…								
								 					Article
				
				Use of Multivariate Data Analysis in Bioprocessing
								
	Apr 06, 2015 
	
	By Anurag S. Rathore, Sumit K. Singh 
	
	BioPharm International 
	The ever increasing demand of biotherapeutics, together with the pressure to contain healthcare costs have motiva…								
								 					Article
				
				SEC in the Modern Downstream Purification Process
								
	Mar 01, 2015 
	
	By R. Christopher Manzari, J. Kevin O'Donnell 
	
	BioPharm International 
	
	Volume 3, Issue 28 
	
	Since the introduction of commercial chromatography resins approximately six de…								
								 					Article
				
				Fermentation for the Future
								Jan 01, 2015 
	
	By Cynthia Challener, PhD 
	
	Microorganisms—bacteria and yeast—have been widely used for the production of genetically engineered (recombinant) biopharmaceuticals. Typical examples…								
								 					Article
				
				Defining Critical Quality Attributes for Monoclonal Antibody Therapeutic Products
								Identifying CQAs for a biotech therapeutic is the first and arguably the most difficult step in implementation of quality by design (QbD) for development and production of biopharmaceuticals (3, 4).  …								
								 					Article
				
				Bureaucratic Roadblocks Threaten Biopharma Growth
								This is particularly true in knowledge-intensive sectors such as biopharmaceuticals.
	
	
		The good news is that some mature and emerging economies are making growing use of patent systems to facilita…								
								 					Article
				
				Trends in Downstream Bioprocessing
								
	Downstream processing involves the recovery and purification of protein therapeutics for biopharmaceuticals, vaccines, and other biologics. It involves the removal of insoluble cell debris and parti…								
								 					Article
				
				Regulatory Challenges in the QbD Paradigm
								The authors demonstrate how an integrated model is helping to achieve regulatory flexibility. This article is part of a special section on biopharmaceutical trends.
	
	
	
	
		With the dawn of the 2…								
								 					Article
				
				Addressing the Challenges in Downstream Processing Today and Tomorrow
								In Quality by Design for Biopharmaceuticals: Principles and Case Studies, A.S. Rathore and R Mhatre eds. (John Wiley & Sons, Inc., Hoboken, New Jersey, 2009) pp 9-27. 
	
	53. FDA, Notice of pilot prog…								
								 					Article
				
				Using Digital Twins to Model Process Chromatography
								
	Mechanistic models provide process understanding for developing robust manufacturing processes and for scale up and tech transfer. 
	By Jennifer Markarian 
	A digital twin is a model of a proces…